{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:14Z","timestamp":1792788194803,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by SPEAC \u2013 under the Special Populations Work Group and\/or CEPI."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"DOI":"10.1186\/s12978-025-02004-2","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T08:25:31Z","timestamp":1744964731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Mabel","family":"Berrueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ciapponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamile","family":"Ballivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Sambade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Stegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Comand\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P. K.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre M.","family":"Buekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"issue":"4","key":"2004_CR1","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","volume":"17","author":"FJ Burt","year":"2017","unstructured":"Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E, et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017;17(4):e107\u201317.","journal-title":"Lancet Infect Dis"},{"key":"2004_CR2","unstructured":"Expansi\u00f3n geogr\u00e1fica de los casos de dengue y chikungunya m\u00e1s all\u00e1 de las \u00e1reas hist\u00f3ricas de transmisi\u00f3n en la Regi\u00f3n de las Am\u00e9ricas [Internet]. [cited 2025 Feb 5]. Available from: https:\/\/www.who.int\/es\/emergencies\/disease-outbreak-news\/item\/2023-DON448"},{"issue":"100673","key":"2004_CR3","volume":"30","author":"WM de Souza","year":"2024","unstructured":"de Souza WM, Ribeiro GS, de Lima STS, de Jesus R, Moreira FRR, Whittaker C, et al. Chikungunya: a decade of burden in the Americas. Lancet Reg Health Am. 2024;30(100673): 100673.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"2004_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13690-023-01081-8","volume":"81","author":"LM Skalinski","year":"2023","unstructured":"Skalinski LM, Santos AES, Paix\u00e3o E, Itaparica M, Barreto F, da Concei\u00e7\u00e3o Nascimento Costa M, et al. Chikungunya seroprevalence in population-based studies: a systematic review and meta-analysis. Arch Public Health. 2023;81(1):80.","journal-title":"Arch Public Health."},{"issue":"1","key":"2004_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010069","volume":"16","author":"AA Bettis","year":"2022","unstructured":"Bettis AA, L\u2019Azou Jackson M, Yoon IK, Breugelmans JG, Goios A, Gubler DJ, et al. The global epidemiology of chikungunya from 1999 to 2020: a systematic literature review to inform the development and introduction of vaccines. PLoS Negl Trop Dis. 2022;16(1): e0010069.","journal-title":"PLoS Negl Trop Dis"},{"key":"2004_CR6","unstructured":"Emerging and Zoonotic Infectious Diseases & CDC. Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013\u20132014."},{"issue":"17","key":"2004_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","volume":"67","author":"R Rosenberg","year":"2018","unstructured":"Rosenberg R, Lindsey NP, Fischer M, Gregory CJ, Hinckley AF, Mead PS, et al. Vital signs: trends in reported vectorborne disease cases\u2014United States and territories, 2004\u20132016. MMWR Morb Mortal Wkly Rep. 2018;67(17):496\u2013501.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2004_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4269\/ajtmh.17-0668","volume":"98","author":"NP Lindsey","year":"2018","unstructured":"Lindsey NP, Staples JE, Fischer M. Chikungunya virus disease among travelers-United States, 2014\u20132016. Am J Trop Med Hyg. 2018;98(1):192\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2004_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12879-016-1417-2","volume":"16","author":"L Furuya-Kanamori","year":"2016","unstructured":"Furuya-Kanamori L, Liang S, Milinovich G, Soares Magalhaes RJ, Clements ACA, Hu W, et al. Co-distribution and co-infection of chikungunya and dengue viruses. BMC Infect Dis. 2016;16(1):84.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"2004_CR10","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/cid\/ciw589","volume":"63","author":"JJ Waggoner","year":"2016","unstructured":"Waggoner JJ, Gresh L, Vargas MJ, Ballesteros G, Tellez Y, Soda KJ, et al. Viremia and clinical presentation in Nicaraguan patients infected with Zika virus, Chikungunya virus, and dengue virus. Clin Infect Dis. 2016;63(12):1584\u201390.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2004_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050060","volume":"5","author":"P G\u00e9rardin","year":"2008","unstructured":"G\u00e9rardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La R\u00e9union. PLoS Med. 2008;5(3): e60.","journal-title":"PLoS Med"},{"issue":"6","key":"2004_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0368-2315(06)76447-X","volume":"35","author":"Y Lenglet","year":"2006","unstructured":"Lenglet Y, Barau G, Robillard PY, Randrianaivo H, Michault A, Bouveret A, et al. Chikungunya infection in pregnancy: evidence for intrauterine infection in pregnant women and vertical transmission in the parturient Survey of the Reunion Island outbreak. J Gynecol Obstet Biol Reprod. 2006;35(6):578\u201383.","journal-title":"J Gynecol Obstet Biol Reprod."},{"issue":"Pt 9","key":"2004_CR13","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1099\/vir.0.82858-0","volume":"88","author":"AM Powers","year":"2007","unstructured":"Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88(Pt 9):2363\u201377.","journal-title":"J Gen Virol"},{"key":"2004_CR14","unstructured":"[cited 2025 Feb 6]. Available from: https:\/\/www.cdc.gov\/chikungunya\/transmission\/index.html"},{"issue":"11","key":"2004_CR15","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3201\/eid1211.051560","volume":"12","author":"V Watanaveeradej","year":"2006","unstructured":"Watanaveeradej V, Endy TP, Simasathien S, Kerdpanich A, Polprasert N, Aree C, et al. The study transplacental chikungunya virus antibody kinetics. Thailand Emerg Infect Dis. 2006;12(11):1770\u20132.","journal-title":"Thailand Emerg Infect Dis"},{"issue":"10","key":"2004_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/INF.0000000000001261","volume":"35","author":"M Rodr\u00edguez-Nieves","year":"2016","unstructured":"Rodr\u00edguez-Nieves M, Garc\u00eda-Garc\u00eda I, Garc\u00eda-Fragoso L. Perinatally acquired Chikungunya infection: the Puerto Rico experience. Pediatr Infect Dis J. 2016;35(10):1163.","journal-title":"Pediatr Infect Dis J"},{"key":"2004_CR17","unstructured":"[cited 2025 Feb 6]. Available from: https:\/\/www.researchgate.net\/profile\/Celia-Christie\/publication\/309878781_Chikungunya_in_Jamaica_-_Public_Health_Effects_and_Clinical_Features_in_Children\/links\/5a14705faca27273c9eafe1f\/Chikungunya-in-Jamaica-Public-Health-Effects-and-Clinical-Features-in-Children"},{"issue":"7","key":"2004_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002996","volume":"8","author":"P G\u00e9rardin","year":"2014","unstructured":"G\u00e9rardin P, Samp\u00e9riz S, Ramful D, Boumahni B, Bintner M, Alessandri JL, et al. Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island. PLoS Negl Trop Dis. 2014;8(7): e2996.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2004_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211036","volume":"14","author":"B Siva Raghavendhar","year":"2019","unstructured":"Siva Raghavendhar B, Patel AK, Kabra SK, Lodha R, Ratageri VH, Ray P. Virus load and clinical features during the acute phase of Chikungunya infection in children. PLoS One. 2019;14(2): e0211036.","journal-title":"PLoS One"},{"issue":"12","key":"2004_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000914","volume":"2","author":"DK Nyamwaya","year":"2022","unstructured":"Nyamwaya DK, Thumbi SM, Bejon P, Warimwe GM, Mokaya J. The global burden of Chikungunya fever among children: a systematic literature review and meta-analysis. PLOS Glob Public Health. 2022;2(12): e0000914.","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"2004_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/tropej\/fmw051","volume":"63","author":"A Kumar","year":"2017","unstructured":"Kumar A, Best C, Benskin G. Epidemiology, clinical and laboratory features and course of Chikungunya among a cohort of children during the first Caribbean epidemic. J Trop Pediatr. 2017;63(1):43\u20139.","journal-title":"J Trop Pediatr"},{"issue":"5","key":"2004_CR22","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1016\/S2666-5247(23)00033-2","volume":"4","author":"WM de Souza","year":"2023","unstructured":"de Souza WM, de Lima STS, Sim\u00f5es Mello LM, Candido DS, Buss L, Whittaker C, et al. Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study. Lancet Microbe. 2023;4(5):e319\u201329.","journal-title":"Lancet Microbe"},{"issue":"6","key":"2004_CR23","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.4269\/ajtmh.16-0719","volume":"98","author":"F Dorl\u00e9ans","year":"2018","unstructured":"Dorl\u00e9ans F, Hoen B, Najioullah F, Herrmann-Storck C, Schepers KM, Abel S, et al. Outbreak of Chikungunya in the french Caribbean islands of Martinique and Guadeloupe: findings from a hospital-based surveillance system (2013\u20132015). Am J Trop Med Hyg. 2018;98(6):1819\u201325.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2004_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009055","volume":"15","author":"CJ Puntasecca","year":"2021","unstructured":"Puntasecca CJ, King CH, LaBeaud AD. Measuring the global burden of chikungunya and Zika viruses: a systematic review. PLoS Negl Trop Dis. 2021;15(3): e0009055.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2004_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nm.2105","volume":"16","author":"W Akahata","year":"2010","unstructured":"Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med. 2010;16(3):334\u20138.","journal-title":"Nat Med"},{"issue":"6","key":"2004_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","volume":"62","author":"R Edelman","year":"2000","unstructured":"Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62(6):681\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"2004_CR27","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/infdis\/jiu014","volume":"209","author":"CJ Roy","year":"2014","unstructured":"Roy CJ, Adams AP, Wang E, Plante K, Gorchakov R, Seymour RL, et al. Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. J Infect Dis. 2014;209(12):1891\u20139.","journal-title":"J Infect Dis"},{"issue":"9959","key":"2004_CR28","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","volume":"384","author":"LJ Chang","year":"2014","unstructured":"Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet. 2014;384(9959):2046\u201352.","journal-title":"Lancet"},{"issue":"5","key":"2004_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","volume":"15","author":"K Ramsauer","year":"2015","unstructured":"Ramsauer K, Schwameis M, Firbas C, M\u00fcllner M, Putnak RJ, Thomas SJ, et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect Dis. 2015;15(5):519\u201327.","journal-title":"Lancet Infect Dis"},{"issue":"10165","key":"2004_CR30","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","volume":"392","author":"EC Reisinger","year":"2019","unstructured":"Reisinger EC, Tschismarov R, Beubler E, Wiedermann U, Firbas C, Loebermann M, et al. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. Lancet. 2019;392(10165):2718\u201327.","journal-title":"Lancet"},{"key":"2004_CR31","unstructured":"ClinicalTrials.gov [Internet]. [cited 2025 Feb 5]. Available from: https:\/\/clinicaltrials.gov\/search?cond=NCT04650399"},{"key":"2004_CR32","unstructured":"ClinicalTrials.gov [Internet]. [cited 2025 Feb 5]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT04546724"},{"issue":"10394","key":"2004_CR33","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","volume":"401","author":"M Schneider","year":"2023","unstructured":"Schneider M, Narciso-Abraham M, Hadl S, McMahon R, Toepfer S, Fuchs U, et al. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2023;401(10394):2138\u201347.","journal-title":"Lancet"},{"key":"2004_CR34","doi-asserted-by":"publisher","unstructured":"Roques P, Fritzer A, Dereuddre-Bosquet N, Wressnigg N, Hochreiter R, Bossevot L, et al. Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera. JCI Insight. 2022;7(14). Available from: https:\/\/doi.org\/10.1172\/jci.insight.160173","DOI":"10.1172\/jci.insight.160173"},{"issue":"9","key":"2004_CR35","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S1473-3099(22)00226-2","volume":"22","author":"SR Bennett","year":"2022","unstructured":"Bennett SR, McCarty JM, Ramanathan R, Mendy J, Richardson JS, Smith J, et al. Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial. Lancet Infect Dis. 2022;22(9):1343\u201355.","journal-title":"Lancet Infect Dis"},{"key":"2004_CR36","doi-asserted-by":"crossref","unstructured":"Raju S, Adams LJ, Earnest JT, Warfield K, Vang L, Crowe JE Jr, et al. (2023) A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans. Sci Transl Med. 15(696):eade8273.","DOI":"10.1126\/scitranslmed.ade8273"},{"key":"2004_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fimmu.2020.00592","volume":"11","author":"S Schrauf","year":"2020","unstructured":"Schrauf S, Tschismarov R, Tauber E, Ramsauer K. Current efforts in the development of vaccines for the prevention of Zika and Chikungunya virus infections. Front Immunol. 2020;11:592.","journal-title":"Front Immunol"},{"issue":"14","key":"2004_CR38","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jama.2020.2477","volume":"323","author":"GL Chen","year":"2020","unstructured":"Chen GL, Coates EE, Plummer SH, Carter CA, Berkowitz N, Conan-Cibotti M, et al. Effect of a Chikungunya virus-like particle vaccine on safety and tolerability Outcomes: a randomized clinical trial: a randomized clinical trial. JAMA. 2020;323(14):1369\u201377.","journal-title":"JAMA"},{"key":"2004_CR39","unstructured":"ClinicalTrials.gov [Internet]. [cited 2025 Feb 5]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03325075."},{"key":"2004_CR40","unstructured":"ClinicalTrials.gov [Internet]. [cited 2025 Feb 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04566484?cond=NCT04566484&rank=1&tab=table#trial-description"},{"key":"2004_CR41","unstructured":"Center for Biologics Evaluation, Research. U.S. Food and Drug Administration. FDA; 2024 [cited 2025 Feb 6]. IXCHIQ. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/ixchiq"},{"issue":"1","key":"2004_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41541-023-00722-x","volume":"8","author":"N Cherian","year":"2023","unstructured":"Cherian N, Bettis A, Deol A, Kumar A, Di Fabio JL, Chaudhari A, et al. Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need. NPJ Vaccines. 2023;8(1):123.","journal-title":"NPJ Vaccines"},{"key":"2004_CR43","unstructured":"[cited 2025 Feb 6]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2024-02-28-29\/05-Chikungunya-hills-508.pdf"},{"key":"2004_CR44","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions [Internet]. 2nd ed. Higgins J, Thomas J, editors. Hoboken, NJ: Wiley-Blackwell; 2019. 736 p. (Wiley Cochrane Series). Available from: https:\/\/play.google.com\/store\/books\/details?id=cTqyDwAAQBAJ","DOI":"10.1002\/9781119536604"},{"key":"2004_CR45","doi-asserted-by":"crossref","unstructured":"Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, et al. Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol. 2017;91:23\u201330.","DOI":"10.1016\/j.jclinepi.2017.08.010"},{"key":"2004_CR46","unstructured":"World Health Organization. Regional Office for Europe. Guidance on an adapted evidence to recommendation process for National Immunization Technical Advisory Groups [Internet]. World Health Organization. Regional Office for Europe; 2022 [cited 2025 Feb 6]. Report No.: WHO\/EURO:2022\u20135497\u201345262\u201364756. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/356896"},{"issue":"3","key":"2004_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3): e1003583.","journal-title":"PLoS Med"},{"key":"2004_CR48","doi-asserted-by":"crossref","unstructured":"Kahale LA, Elkhoury R, El Mikati I, Pardo-Hernandez H, Khamis AM, Sch\u00fcnemann HJ, et al. Tailored PRISMA 2020 flow diagrams for living systematic reviews: a methodological survey and a proposal. F1000Res. 2021;10(192):192.","DOI":"10.12688\/f1000research.51723.2"},{"issue":"49","key":"2004_CR49","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","volume":"34","author":"J Bonhoeffer","year":"2016","unstructured":"Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, et al. Global alignment of immunization safety assessment in pregnancy\u2014The GAIA project. Vaccine. 2016;34(49):5993\u20137.","journal-title":"Vaccine"},{"key":"2004_CR50","unstructured":"Chikungunya Outbreak Toolbox [Internet]. [cited 2025 Feb 6]. Available from: https:\/\/www.who.int\/emergencies\/outbreak-toolkit\/disease-outbreak-toolboxes\/chikungunya-outbreak-toolbox"},{"issue":"3","key":"2004_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses inRwith themetaforPackage. J Stat Softw. 2010;36(3):1\u201348.","journal-title":"J Stat Softw"},{"key":"2004_CR52","unstructured":"https:\/\/methods.cochrane.org\/robins-i."},{"key":"2004_CR53","unstructured":"https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"2004_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.11120\/msor.2001.01010023","volume":"1","author":"BD Ripley","year":"2001","unstructured":"Ripley BD. The R project in statistical computing. MSOR Connect. 2001;1:23\u20135.","journal-title":"MSOR Connect"},{"key":"2004_CR55","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:1686.","journal-title":"J Open Source Softw."},{"key":"2004_CR56","doi-asserted-by":"crossref","unstructured":"Doi J, Potter G, Wong J, Alcaraz I, Chi P. Web application teaching tools for statistics using R and shiny. Technol Innov Stat Edu. 2016;9.","DOI":"10.5070\/T591027492"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-025-02004-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T08:25:37Z","timestamp":1744964737000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-025-02004-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2004"],"URL":"https:\/\/doi.org\/10.1186\/s12978-025-02004-2","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not required for this study, given that this is a protocol for a systematic review and meta-analysis using published data. The systematic review and living meta-analysis results will be widely disseminated via the online dashboards described above. One or more summary papers will be submitted to a leading peer-reviewed journal in this field, adhering to the PRISMA statement\/extension for reporting LSR. (56).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and dissemination"}},{"value":"Not applicable. This study does not involve individual patient data or identifiable personal information requiring consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"56"}}